NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype

Nature Communications

Volumn 4, Issue , 2013, Pages

  Yamamoto, Mizuki ^a,b   Taguchi, Yuu ^a   Ito Kureha, Taku ^c   Semba, Kentaro ^b   Yamaguchi, Noritaka ^d   Inoue, Jun Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b WASEDA UNIVERSITY   (Japan)

^c OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; I KAPPA B; JAGGED1; NOTCH RECEPTOR;

CANCER; CELL ORGANELLE; GENE EXPRESSION; WOMENS HEALTH;

ARTICLE; BASAL LIKE BREAST CANCER; BREAST CANCER; CANCER STEM CELL; CELL EXPANSION; CELL POPULATION; CELL SUBPOPULATION; ENZYME ACTIVATION; EPIGENETICS; GENE CONTROL; HUMAN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR MICROENVIRONMENT;

CALCIUM-BINDING PROTEINS; CARCINOMA, BASAL CELL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, NOTCH; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84883097117     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3299     Document Type: Article

References (51)

1. Vargo-Gogola, T. & Rosen, J. Modelling breast cancer: one size does not fit all. Nat. Rev. Cancer 7, 659-672 (2007). (Pubitemid 47327411)
2. Herschkowitz, J. I. et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome. Biol. 8, R76 (2007).
3. Sorlie, T. et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA 100, 8418-8423 (2003). (Pubitemid 36842560)
4. Rakha, E., Reis-Filho, J. & Ellis, I. Basal-like breast cancer: a critical review. J. Clin. Oncol. 26, 2568-2581 (2008).
5. Yamaguchi, N. et al. Constitutive activation of nuclear factor-kB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines. Cancer Sci. 100, 1668-1674 (2009).
6. Hayden, M. S. & Ghosh, S. Shared principles in NF-kB signaling. Cell 132, 344-362 (2008).
7. Häcker, H. & Karin, M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13 (2006).
8. Sun, S. C. Controlling the fate of NIK: a central stage in noncanonical NF-kB signaling. Sci. Signal 3, pe18 (2010).
9. Perkins, N. D. Integrating cell-signalling pathways with NF-kB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62 (2007). (Pubitemid 46012014)
10. Dalerba, P., Cho, R. W. & Clarke, M. F. Cancer stem cells: models and concepts. Annu. Rev. Med. 58, 267-284 (2007). (Pubitemid 46706514)
11. Visvader, J. E. & Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755-768 (2008).
12. Cao, Y., Luo, J. L. & Karin, M. IkB kinase a kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. Proc. Natl Acad. Sci. USA 104, 15852-15857 (2007). (Pubitemid 350035388)
13. Liu, M. et al. The canonical NF-kB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res. 70, 10464-10473 (2010).
14. Zhou, J. et al. NF-kB pathway inhibitors preferentially inhibit breast cancer stem-like cells. Breast Cancer Res. Treat. 111, 419-427 (2008).
15. Murohashi, M. et al. Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells. Br. J. Cancer 102, 206-212 (2010).
16. Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15, 907-913 (2009).
17. Molyneux, G. et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7, 403-417 (2010).
18. Visvader, J. E. Cells of origin in cancer. Nature 469, 314-322 (2011).
19. Keller, P. J. et al. Defining the cellular precursors to human breast cancer. Proc. Natl Acad. Sci. USA 109, 2772-2777 (2012).
20. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988 (2003). (Pubitemid 36418143)
21. Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567 (2007). (Pubitemid 350056407)
22. Charafe-Jauffret, E. et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69, 1302-1313 (2009).
23. Balkwill, F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 9, 361-371 (2009).
24. Iliopoulos, D. et al. An epigenetic switch involving NF-kB, Lin28, Let-7 microRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706 (2009).
25. Harrison, H. et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 70, 709-718 (2010).
26. Bouras, T. et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 3, 429-441 (2008).
27. Dontu, G. et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 6, R605-R615 (2004).
28. Bray, S. J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7, 678-689 (2006). (Pubitemid 44268213)
29. Iso, T. et al. HERP, a new primary target of Notch regulated by ligand binding. Mol. Cell Biol. 21, 6071-6079 (2001). (Pubitemid 32737821)
30. Iso, T. et al. HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell Physiol. 194, 237-255 (2003). (Pubitemid 36176887)
31. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
32. Tian, B., Nowak, D. E., Jamaluddin, M., Wang, S. & Brasier, A. R. Identification of direct genomic targets downstream of the nuclear factor-kB transcription factor mediating tumor necrosis factor signaling. J. Biol. Chem. 280, 17435-17448 (2005). (Pubitemid 41389215)
33. Mootha, V. K. et al. PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003). (Pubitemid 36792858)
34. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005). (Pubitemid 41528093)
35. Niida, A. et al. Gene set-based module discovery in the breast cancer transcriptome. BMC Bioinformatics 10, 71 (2009).
36. Yamamoto, M. et al. Epigenetic alteration of the NF-kB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer. Cancer Sci. 101, 2391-2397 (2010).
37. Liao, G. et al. Regulation of the NF-kB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279, 26243-26250 (2004). (Pubitemid 38798772)
38. Joshi, P. A. et al. Progesterone induces adult mammary stem cell expansion. Nature 465, 803-807 (2010).
39. Asselin-Labat, M. L. et al. Control of mammary stem cell function by steroid hormone signalling. Nature 465, 798-802 (2010).
40. Reedijk, M. et al. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res. Treat. 111, 439-448 (2008).
41. Reedijk, M. et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 65, 8530-8537 (2005). (Pubitemid 41330622)
42. Dickson, B. C. et al. High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod. Pathol. 20, 685-693 (2007). (Pubitemid 46788875)
43. Lambe, M. et al. Transient increase in the risk of breast cancer after giving birth. N. Engl. J. Med. 331, 5-9 (1994). (Pubitemid 24195593)
44. LaVoie, M. J. et al. The Notch ligands, Jagged and Delta, are sequentially processed by a-secretase and presenilin/g-secretase and release signaling fragments. J. Biol. Chem. 278, 34427-34437 (2003).
45. Kao, H. Y. et al. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev. 12, 2269-2277 (1998).
46. Pratt, M. A. et al. The canonical NF-kB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population. Oncogene 28, 2710-2722 (2009).
47. Johnston, D. A., Dong, B. & Hughes, C. C. TNF induction of jagged-1 in endothelial cells is NFkB-dependent. Gene 435, 36-44 (2009).
48. Sansone, P. et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117, 3988-4002 (2007). (Pubitemid 350224108)
49. Yamaguchi, N. et al. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res. 68, 1881-1888 (2008). (Pubitemid 351416574)
50. Gohda, J. et al. RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. EMBO J. 24, 790-799 (2005). (Pubitemid 40396108)
51. Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500-501 (2006).